Follow the people · Insider

WL

William Lewis

Insider · Chair and CEO · INSM

William Lewis files insider transactions with the SEC as a chair and ceo of Insmed (INSM). We hold 20 disclosed purchases and sales filed since 27 October 2010, 3 of them in the last 90 days.

  • Files forINSM
  • Disclosed buys and sells20 in all, 3 in the last 90 days
  • Last disclosure24 July 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 10 September 201223 July 2026Chair and CEO · Insmed (INSM)543 Form 4 lines · source: SEC Form 4
  • Filed 4 January 20247 January 2026Director · NewAmsterdam Pharma Co (NAMS)7 Form 4 lines · source: SEC Form 4
  • Filed 27 January 201727 January 2017Director · uniQure (QURE)2 Form 4 lines · source: SEC Form 4
  • Filed 21 October 201027 October 2010President, PFO and Treasurer · Aegerion Pharmaceuticals (AEGR)7 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.